The Clorox Company (NYSE:CLX) Shares Sold by Strategy Asset Managers LLC

Strategy Asset Managers LLC reduced its position in The Clorox Company (NYSE:CLX) by 68.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,319 shares of the company’s stock after selling 2,851 shares during the period. Strategy Asset Managers LLC’s holdings in The Clorox were worth $255,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Northern Trust Corp lifted its stake in shares of The Clorox by 0.9% in the 4th quarter. Northern Trust Corp now owns 2,099,188 shares of the company’s stock valued at $423,868,000 after purchasing an additional 18,380 shares in the last quarter. Norges Bank acquired a new position in The Clorox during the 4th quarter worth approximately $254,283,000. Stifel Financial Corp lifted its position in The Clorox by 3.9% during the 4th quarter. Stifel Financial Corp now owns 1,089,565 shares of the company’s stock worth $220,008,000 after acquiring an additional 40,921 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in The Clorox by 10.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,027,634 shares of the company’s stock worth $207,500,000 after acquiring an additional 93,314 shares in the last quarter. Finally, UBS Asset Management Americas Inc. lifted its position in The Clorox by 7.9% during the 4th quarter. UBS Asset Management Americas Inc. now owns 969,091 shares of the company’s stock worth $195,679,000 after acquiring an additional 70,709 shares in the last quarter. 78.10% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts have issued reports on CLX shares. Atlantic Securities upgraded The Clorox from a “neutral” rating to an “overweight” rating and set a $233.00 price objective on the stock in a report on Friday, February 19th. Deutsche Bank Aktiengesellschaft dropped their price objective on The Clorox from $195.00 to $186.00 and set a “hold” rating on the stock in a report on Monday, May 3rd. Argus lowered their price objective on The Clorox from $230.00 to $206.00 and set a “buy” rating for the company in a research note on Friday, May 21st. Royal Bank of Canada restated a “neutral” rating on shares of The Clorox in a research note on Wednesday, May 5th. Finally, DA Davidson lowered their price objective on The Clorox from $189.00 to $177.00 and set a “neutral” rating for the company in a research note on Monday, May 3rd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the stock. The Clorox presently has a consensus rating of “Hold” and a consensus target price of $207.94.

Shares of The Clorox stock opened at $176.32 on Friday. The company has a debt-to-equity ratio of 2.65, a quick ratio of 0.70 and a current ratio of 1.08. The firm has a market capitalization of $21.93 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 3.36 and a beta of 0.20. The company has a fifty day moving average price of $184.43. The Clorox Company has a fifty-two week low of $175.25 and a fifty-two week high of $239.87.

The Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 29th. The company reported $1.62 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.48 by $0.14. The business had revenue of $1.78 billion during the quarter, compared to analyst estimates of $1.86 billion. The Clorox had a return on equity of 104.74% and a net margin of 12.27%. The company’s revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.89 earnings per share. As a group, equities research analysts expect that The Clorox Company will post 7.59 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 13th. Stockholders of record on Wednesday, July 28th will be issued a $1.16 dividend. This is a positive change from The Clorox’s previous quarterly dividend of $1.11. The ex-dividend date is Tuesday, July 27th. This represents a $4.64 annualized dividend and a dividend yield of 2.63%. The Clorox’s dividend payout ratio is 60.33%.

About The Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Further Reading: Is a Roth IRA right for you?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.